GB9918779D0 - Formulations for parenteral use of estramustine phosphate and albumin - Google Patents

Formulations for parenteral use of estramustine phosphate and albumin

Info

Publication number
GB9918779D0
GB9918779D0 GBGB9918779.1A GB9918779A GB9918779D0 GB 9918779 D0 GB9918779 D0 GB 9918779D0 GB 9918779 A GB9918779 A GB 9918779A GB 9918779 D0 GB9918779 D0 GB 9918779D0
Authority
GB
United Kingdom
Prior art keywords
albumin
formulations
parenteral use
estramustine phosphate
estramustine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9918779.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Priority to GBGB9918779.1A priority Critical patent/GB9918779D0/en
Publication of GB9918779D0 publication Critical patent/GB9918779D0/en
Priority to SK178-2002A priority patent/SK1782002A3/en
Priority to EP00949471A priority patent/EP1206266A2/en
Priority to IL14774500A priority patent/IL147745A0/en
Priority to EA200200234A priority patent/EA200200234A1/en
Priority to PCT/EP2000/007678 priority patent/WO2001010446A2/en
Priority to CA002380312A priority patent/CA2380312A1/en
Priority to PL00353406A priority patent/PL353406A1/en
Priority to BR0013276-4A priority patent/BR0013276A/en
Priority to MXPA02001395A priority patent/MXPA02001395A/en
Priority to JP2001514963A priority patent/JP2003506408A/en
Priority to NZ517632A priority patent/NZ517632A/en
Priority to KR1020027001700A priority patent/KR20020019967A/en
Priority to CNA008114420A priority patent/CN1511037A/en
Priority to HU0202645A priority patent/HUP0202645A3/en
Priority to AU62809/00A priority patent/AU6280900A/en
Priority to CZ2002376A priority patent/CZ2002376A3/en
Priority to NO20020631A priority patent/NO20020631D0/en
Priority to ZA200201955A priority patent/ZA200201955B/en
Ceased legal-status Critical Current

Links

GBGB9918779.1A 1999-08-09 1999-08-09 Formulations for parenteral use of estramustine phosphate and albumin Ceased GB9918779D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9918779.1A GB9918779D0 (en) 1999-08-09 1999-08-09 Formulations for parenteral use of estramustine phosphate and albumin
CZ2002376A CZ2002376A3 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
BR0013276-4A BR0013276A (en) 1999-08-09 2000-08-03 Pharmaceutical formulation for parenteral use comprising estramustine phosphate as active ingredient
JP2001514963A JP2003506408A (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
IL14774500A IL147745A0 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
EA200200234A EA200200234A1 (en) 1999-08-09 2000-08-03 PREPARATIONS FOR PARENTERAL APPLICATION OF ESTRAMUSTINES OF PHOSPHATE AND ALBUMIN
PCT/EP2000/007678 WO2001010446A2 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
CA002380312A CA2380312A1 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
PL00353406A PL353406A1 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
SK178-2002A SK1782002A3 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
MXPA02001395A MXPA02001395A (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin.
EP00949471A EP1206266A2 (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
NZ517632A NZ517632A (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
KR1020027001700A KR20020019967A (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
CNA008114420A CN1511037A (en) 1999-08-09 2000-08-03 Nonintestinal estramustine phosphate and albumin preparations
HU0202645A HUP0202645A3 (en) 1999-08-09 2000-08-03 Fornulations for parenteral use of estramustine phosphate and albumin
AU62809/00A AU6280900A (en) 1999-08-09 2000-08-03 Formulations for parenteral use of estramustine phosphate and albumin
NO20020631A NO20020631D0 (en) 1999-08-09 2002-02-08 Formulations for parenteral use of estramustine phosphate and albumin
ZA200201955A ZA200201955B (en) 1999-08-09 2002-03-08 Formulations for parenteral use of estramustine phosphate and albumin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9918779.1A GB9918779D0 (en) 1999-08-09 1999-08-09 Formulations for parenteral use of estramustine phosphate and albumin

Publications (1)

Publication Number Publication Date
GB9918779D0 true GB9918779D0 (en) 1999-10-13

Family

ID=10858862

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9918779.1A Ceased GB9918779D0 (en) 1999-08-09 1999-08-09 Formulations for parenteral use of estramustine phosphate and albumin

Country Status (2)

Country Link
GB (1) GB9918779D0 (en)
ZA (1) ZA200201955B (en)

Also Published As

Publication number Publication date
ZA200201955B (en) 2003-05-28

Similar Documents

Publication Publication Date Title
HUP0202477A3 (en) Use of phthalazine derivatives
HUP0200898A3 (en) Derivatives of venlafaxine and methods of preparing and using the same
HK1038185A1 (en) Sustained release preparations
EP1047431A4 (en) Pharmaceutically active compounds and methods of use thereof
TW427126U (en) Connection structure for fixture and containing article
EP1115396A4 (en) Pharmaceutically active compounds and methods of use thereof
GB2367103B (en) Connector and method of use of the connector
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
HUP0202729A3 (en) Compositions for parenteral use of estramustine phosphate and amino acids
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
IL147745A0 (en) Formulations for parenteral use of estramustine phosphate and albumin
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9918779D0 (en) Formulations for parenteral use of estramustine phosphate and albumin
HK1041227B (en) Sustained release implant and methods for preparation thereof
IL133612A0 (en) Formulations containing estramustine phosphate and albumin
PL350963A1 (en) Use of arylalkanoylpyridazines
PL342767A1 (en) Thiagabin preparations of prolonged release and reduced side-effects
HUP0201610A3 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
GB9911546D0 (en) Release of poorly soluble agents
AU6230499A (en) Method for preparing 2-chloropropionaldehyde and use of the same
GB9921954D0 (en) Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
ITMI991998A0 (en) FORMULATIONS OF ESTRAMUSTINE PHOSPHATE AND ALBUMIN FOR PARENTERAL USE
AU7609200A (en) Event based system for use within the creation and implementation of educationalsimulations
AU5098099A (en) Preparation and use of alpha-keto bisphosphonates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)